Report Overview

The Global Opioid Addiction Treatment market size stood at USD 2.81 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Opioid Use Disorder (OUD) is a chronic condition associated with compulsive, prolonged, and repeated self-administration of opioids. There are two types of patients suffering from OUD: patients who are addicted to non-medical opioids and patients addicted to medical opioids. A single factor cannot be accounted for OUD, but a combination of environmental and genetic factors influences the patient



Market Drivers

Usage of opioids causes addiction, andopioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence.These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. The rising use of opioids for the management of pain, large healthcare expenditure, and rising chronic disorders is driving the growth of the market

Recent FDA approval of first non-opioid treatment for the management of opioid withdrawal symptoms in adults is propelling the opioid withdrawal treatment market

Additionally, the rising population affected with chronic disorders, along with favourable reimbursement scenarios, is driving the growth of the market. For instance, according to the United Nations, the older population is likely to reach 425 million by 2050. Additionally, according to the World Health Organization (WHO), in 201, more than 17.7 million people died from cardiovascular diseases contributing to 31% of all the global deaths. This rise in the aging population will lead to a rise in cardiovascular disorders as this population is highly prone to various heart disorders and is at a higher risk of developing complications which are also likely to drive the market